All the latest news on the marijuana space delivered directly to your inbox.

Biosynthesis: The Science That May Unlock The Medical Potential Of Cannabis

Vancouver, BC – January 18, 2017 – Choom™ (CSE: CHOO; OTCQB: CHOOF) is pleased to announce it has signed a Letter of Intent to acquire its second, advanced-stage cannabis production licence applicant ("Target") under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). The target, which is located on Vancouver Island, B.C. is at the “Confirmation of Readiness Stage” within the Health Canada “ACMPR” application process.

Chris Bogart, President and CEO states, “we are very pleased Choom™ has increased its total production capacity with the addition of our second advanced stage applicant". Upon completion of the tenant improvements, the target will submit its evidence package to Health Canada and it is expected a cannabis cultivation license will soon follow. This acquisition further demonstrates our commitment to building a national premium recreation brand.

Acquisition Terms

Pursuant to the Acquisition, the Company will acquire all of the shares of Target, which will become a wholly-owned subsidiary of the Company, and the Company will issue to the Target shareholders, based on their pro rata holdings, the following:
  • on the closing date, 8, 000, 000 common shares into escrow, 10% of which will be released on the Closing and the balance over 24 months; in equal installments every 6 months, subject to regulatory approvals.
  • $2,000,000 in common shares following receipt by the Target of its cannabis sales license under the ACMPR based on the then trading price of Choom’s common shares (10-day VWAP).
The definitive share purchase agreement will include customary conditions, including obtaining all necessary corporate approvals and applicable exchange acceptances. The Target acquisition is arms-length.


Choom™ was created for and inspired by the Choom Gang; a group of buddies in Honolulu during the 1970’s who loved to smoke weed—or as the locals called it, “Choom”. Now, after four decades, Choom™ is bringing the spirit of Hawaii to the Okanagan and Canada. We’re planting our flag in the rapidly growing legal cannabis industry in Canada with our own brand of high-grade handcrafted herb.

“Chris Bogart”
President & CEO

Contact: Choom Inc.

Chris Bogart
President & CEO
T: 604.683.2509
F: 604.683.2506
Please see full disclaimers on the website applicable to all content provided by TSI, wherever published or re-published:

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 
32x32x1   32x32x2
9375 E Shea Blvd Ste 100
Scottsdale 85260
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.